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https://doi.org/10.1016/j.stemcr.2017.12.014SUMMARYScarce access to primary samples and lack of efficient protocols to generate oligodendrocytes (OLs) from human pluripotent stem cells
(hPSCs) are hampering our understanding of OL biology and the development of novel therapies. Here, we demonstrate that overexpres-
sion of the transcription factor SOX10 is sufficient to generate surface antigen O4-positive (O4+) and myelin basic protein-positive OLs
from hPSCs in only 22 days, including from patients with multiple sclerosis or amyotrophic lateral sclerosis. The SOX10-induced O4+
population resembles primary humanOLs at the transcriptome level and canmyelinate neurons in vivo.Using in vitroOL-neuron co-cul-
tures, myelination of neurons by OLs can also be demonstrated, which can be adapted to a high-throughput screening format to test the
response of pro-myelinating drugs. In conclusion, we provide an approach to generate OLs in a very rapid and efficient manner, which
can be used for disease modeling, drug discovery efforts, and potentially for therapeutic OL transplantation.INTRODUCTION
Oligodendrocytes (OLs) are the central nervous system
(CNS) glial cells responsible for axonal myelination. How-
ever, the complete roles of OLs are still only partially under-
stood and vary depending on the CNS region wherein they
reside (Marques et al., 2016). Myelination in the CNS is
essential for proper signal conduction along neuronal
axons and for maintaining brain homeostasis. Defects in
myelin production and/or maintenance are the predomi-
nant pathological feature of several diseases, including leu-
kodystrophies and multiple sclerosis (MS) (Franklin et al.,
2012). In addition to myelination, OLs have a role in tro-
phic and metabolic support of neurons, fueling oxidative
phosphorylation in the mitochondria of axons. This tro-
phic support is disrupted in amyotrophic lateral sclerosis
(ALS), and defects in OL function contribute to ALS onset
and progression (Lee et al., 2012b).
Lack of insight in human OL biology is in large part a
consequence of the limited access to human OLs and diffi-
culties inmaintaining these cells in vitro. Therefore, having
access to human OLs would represent a major step forward
in studies aimed at understandingmechanisms that are de-
regulated in diseases with OL involvement. Moreover, thisStem Cell Re
This is an open access article under the Cwould allow to test and study if and how candidate drugs
affect the process of OL myelination and remyelination
(Mei et al., 2014; Lariosa-Willingham et al., 2016), and/or
the trophic support provided by OLs.
With the isolation of human embryonic stem cells
(hESCs) and the development of human induced pluripo-
tent stem cell (hiPSC) technology, a number of protocols
have been developed to generate OLs from hPSCs (Nistor
et al., 2005; Hu et al., 2009; Wang et al., 2013; Douvaras
et al., 2014), recapitulating in vitro the molecular signals
and events that occur during in vivoOL development, lead-
ing to myelinating OLs (Wang et al., 2013; Douvaras et al.,
2014). Despite recent optimizations (Douvaras and Fossati,
2015), these protocols remain inefficient and variable in
terms of OL yield and, importantly, require very long differ-
entiation times (>100 days to generatemyelin basic protein
(MBP)-positive OLs). These issues have precluded the use of
patient-specific iPSC-derived OLs to elucidate human OL
biology and disease, and use such cells as platform for
drug screening.
Here, we describe that, by the overexpression of the sin-
gle transcription factor (TF) SOX10 in hPSC-derived neural
precursors (NPCs), it is possible to generate surface antigen
O4 (O4)-positive andMBP+ OLs within only20 days fromports j Vol. 10 j 655–672 j February 13, 2018 j ª 2017 The Authors. 655
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the PSC stage. The transcriptome of hPSC-derived O4+ cells
resembles that of primary intermediate OLs. Similar OL
production in terms of efficiency and time course was ob-
tained from patients with MS or familial ALS (fALS)
compared with healthy donors. Finally, grafting into
homozygous shiverer (Shi/–) mouse brain slices and co-
culture with hPSC-derived neurons confirmed the myeli-
nation capability of SOX10-induced OLs in in vivo and
in vitro contexts. All hPSC-derived OL-neuron co-cultures
were also adapted to high-throughput screening (HTS) for-
mats allowing demonstration of enhanced myelin produc-
tion by different compounds.RESULTS
Selection of TFs Involved in OL Specification
To define which TFs could promote efficient OL differenti-
ation from hPSCs, we selected 16 TFs known to function in
OL specification and/or maturation: ASCL1, AXIN2,MYRF,
MYT1, OLIG1, OLIG2, NKX2-2, NKX6-1, NKX6-2, SOX2,
SOX8, SOX9, SOX10, ST18, ZEB2, and ZNF536 (Cahoy
et al., 2008; Pozniak et al., 2010; Weng et al., 2012; Najm
et al., 2013; Yang et al., 2013). The coding regions of these
genes were individually cloned in the FUW lentiviral doxy-
cycline-inducible expression vector. As reported (Carey
et al., 2009), we demonstrated efficient overexpression of
each TF in an inducible manner in our experimental set-
tings (Figures S1A and S1B).Initial Screening
An initial screen of the 16 selected TFs was performed to
identify TFs that induced early, intermediate, and late OL
fate. NPCs were generated from hPSCs by dual SMAD inhi-
bition in the presence of retinoic acid (RA) and Sonic
hedgehog (SHH) agonist (Chambers et al., 2009). More
than 95% of the day 12 PSC progeny stained positive for
NPC markers (SOX2 and NESTIN) and most of them
(81.8% ± 2.7%) expressed the ventral progenitor marker
HOXB4 (Figure S1C). NPCs were further expanded using
basic fibroblast growth factor (bFGF), and then transducedFigure 1. Screening of the 16 Selected TFs to Evaluate Their Influ
(A) Scheme of the strategy followed for NPC generation, expansion a
(B) Gene expression changes of early (CSPG4 and OLIG2e), intermed
measured by qRT-PCR, expressed as fold change relative to control (N
(C) Staining for A2B5 in the different transduced cell progeny on day
(D) Representative images of the A2B5 stainings of vector control and
as nuclear marker.
(E) Fold change in the expression of the MCS5-SOX10 reporter as a resu
transduced with empty vectors) after 7 days in OL differentiation me
(F) Example of the expression of the MCS5-SOX10 reporter (GFP-FIT
progeny.
Data represented as mean ± SEM of N = 3–4 independent experimentwith each of the 16 individual TFs and cultured in OL dif-
ferentiation medium (Figure 1A).
To identify the TFs that enhanced OL lineage differenti-
ation, we performed qRT-PCRs for early (OLIG2 and
CSPG4), intermediate (ASCL1 and SOX10), and late
(GALC and PLP1) OL lineage markers 7 days after trans-
duction (Figure 1B). Overexpression of ASCL1, NKX6-2,
or MYT1 induced a significant increase in endogenous
(e) transcripts for OLIG2e, CSPG4, and ASCL1e, while
expression of the more mature OL genes, GALC and
PLP1, was significantly induced by overexpression of
SOX8, SOX9, or SOX10. We also performed immunostain-
ing for A2B5, a marker for intermediate oligodendrocyte
precursor cells (OPCs) (Figures 1C and 1D). In the absence
of TF overexpression, we detected 8.02% ± 2.46% A2B5+
cells, consistent with the fact that differentiation was
induced for only 7 days. By contrast, and in line with
the qRT-PCR data, 32.05% ± 4.04% and 47.63% ± 5.33%
A2B5+ cells were identified following overexpression of
ASCL1 and NKX6-2, respectively.
We also transduced the NPCs with a vector containing
the MCS5-SOX10 enhancer region, which is an efficient
and specific reporter for human OL lineage cells (Pol
et al., 2013). Following co-transduction of NPCs with the
individual TFs combined with the MCS5-SOX10 vector,
expression of GFP (activity of the reporter) was evaluated
by fluorescence-activated cell sorting (FACS) 7 days later.
As the MCS5-SOX10 vector also contained a constitutive
mCherry cassette, the fraction of GFP+ cells within the
mCherry+ population was quantified. A 5- to 6-fold in-
crease in eGFP+/mCherry+ cells was identified in NPCs
transduced with either SOX8, SOX9 or SOX10, in line
with the increased expression of mature OL markers (Fig-
ures 1E and 1F).
Thus, overexpression of ASCL1, NKX6-2, and MYT1
induced early-intermediate OL lineage transcripts and
proteins, while overexpression of SOX8, SOX9, and
SOX10 activated the MCS5-SOX10 enhancer-based re-
porter and induced expression of late OL genes (GALC
and PLP1). The effect of these six TFs was then further
analyzed.ence on OL Specification
nd transduction with lentiviral vectors.
iate (ASCL1e and SOX10e), and late (GALC and PLP1) OPC markers
PCs transduced with eGFP).
+7.
ASCL1 and NKX6-2 transduced cells. Hoechst 33258 (blue) was used
lt of the overexpression of the different TFs relative to control (cells
dia.
C) within mCherry+ cells in vector control and SOX10-transduced
s. *p < 0.05. Scale bars: 50 mm.
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Screening with the Six Selected TFs
We used anti-O4 antibody staining (Sommer and Schach-
ner, 1981) to further define which of the six TFs caused dif-
ferentiation to mid- and late-stage OL lineage cells. Day
12 NPCs, without bFGF expansion, were transduced with
the six TFs individually to enable assessment of the shortest
period required to generate OLs from hPSCs, and to avoid
possible lineage skewing due to bFGF-based NPC expan-
sion (Furusho et al., 2015). OL differentiation was assessed
on day 10 after transduction (22 days from undifferenti-
ated hPSCs) (Figure 2A).
Less than 1% of NPCs transduced with an eGFP control
vector were O4+. Transduction of NPCs with ASCL1,
NKX6-2, or MYT1 did not increase the fraction of O4+
cells, consistent with the finding that these TFs
induced immature/intermediate OPC lineage. However,
50.02% ± 3.21%, 37.35% ± 4.51%, and 54.05% ± 2.52%
of NPCs transduced with SOX8, SOX9 or SOX10 were
O4+, respectively (Figure 2B). We next tested if combined
overexpression of SOX10 with any of the other five TFs
would further enhance the proportion of O4+ cells. How-
ever, no further increase in O4+ cells was seen with any
TF combination over SOX10 alone (Figure 2D).
This was confirmed by studies testing OPC/OL marker
transcripts in cells transduced with SOX8, SOX9, or
SOX10 alone, or SOX10 in combination with the other
five TFs (Figure 2E). SOX10e, GALC, CNP, PLP1, and MBP
expression was induced 5- to >100-fold following trans-
duction with SOX10 alone. Transduction with either
SOX8 or SOX9 induced similar, albeit somewhat lower
levels of these transcripts. Combinations of SOX10 with
any of the other TFs did not further enhance marker
expression.
We next FACS sorted O4+ and O4– subpopulations
10 days after transduction with SOX10. The O4+ fraction
was highly enriched for cells expressing OPC/OL marker
transcripts in comparison with the O4– fraction (Fig-
ure 2F), confirming that expression of O4 is specific for in-
termediate and late OL lineage cells. Thus, overexpression
of the TF SOX10 alone is sufficient to induce differentia-
tion of NPCs toward the OL lineage. Subsequent studies
were designed to further characterize the SOX10-induced
cells.Figure 2. Impact of the Six Selected TFs on OPC/OL Specification
(A) Scheme of the strategy followed for NPC generation and direct tr
(B) Evaluation of the expression of O4 by FACS in NPCs transduced with
(C) Representative dot plots of O4 expression and isotype control by
(D) Percentages of O4 expression when NPCs were transduced for 10
(E) Gene expression levels of OPC/OL markers 10 days following trans
(F) Gene expression levels for OPC/OL markers in FACS sorted O4+ and O
to GAPDH. SOX10e refers to its endogenous expression.
Data represented as mean ± SEM of N = 3–5 independent experimentSOX10-Induced Cells Express Typical Markers of OLs
We next tested if SOX10-induced progeny expresses, in
addition to O4, other typical OLmarkers. Immunostaining
on day 10 SOX10-induced cells (22 days from hPSC stage;
without prior O4+ enrichment), demonstrated that day
12 NPCs stained positive for OLIG2 but not O4 (Figure 3A),
while SOX10-transduced cells 10 days after induction were
negative for OLIG2 (not shown). Approximately 50%–60%
of day 22 NPC progeny stained positive for O4 (in line with
the FACS data; Figures 3B, 3C, and 3E) and O1 (Figure S2B),
and that 97.15% ± 8.19% SOX10+ cells co-expressed O4. In
addition, 21.48% ± 2.09% SOX10+ cells also stained posi-
tive for MBP (Figures 3D, 3F, and 3G), with 71.67% ±
2.43% of these cells co-expressing MOG (Figure 3H). PLP
expression was found as well within the SOX10-induced
cells (20.35% ± 3.19%), and remained expressed in most
(94.60% ± 2.57%) of the O4+-purified cells (Figure 3J).
These myelin protein-expressing cells displayed a more
mature OLmorphology, with extendedmembrane sheaths
and highly branched processes (Figures 3C–3J).
Aside from O4+ cells, we also found rare TUJI+ neurons
(<5%; Figure 3I), but no GFAP+ astrocytes in the culture.
We also assessed if Schwann cells (SCs) were present
in the culture, by staining for the SC-specific peripheral
myelin protein 22 (PMP22; Figures S2C and S2D). SOX10-
induced progeny did not contain PMP22+ cells, indicating
that only OLs and not peripheral SCs were generated.
To further prove that generation of O4+/MBP+ cells was
due to SOX10 overexpression, we co-stained SOX10-
induced progeny with SOX10 and MBP. All MBP+ cells
co-expressed SOX10, demonstrating that SOX10 expres-
sion was required for the generation of MBP+ OLs (Fig-
ure 3K). Furthermore, no O4 or MBP expression was
observed in eGFP-transduced NPCs after 10 days of induc-
tion (Figures S2E and S2F).
The yield of O4+ cells on day 22 was approximately
240% of the day 12 NPCs, and 24,000% of the day
0 PSCs. This high yield, also from NPCs, reflects the pres-
ence of proliferative OPCs in the culture that give rise not
only to mature OLs but also to other OPCs. In fact, Ki67+
cells were present throughout differentiation (Figure 3L),
with 24.22% ± 1.20% of Ki67+ cells present in the whole
culture on day 10 after SOX10 induction. However,Alone or in Combination
ansduction for a total period of 22 days from the PSC stage.
the selected six TFs alone after 10 days in OL differentiation media.
FACS of cells transduced with either SOX10 or eGFP.
days with different combinations of the TFs.
duction with single or combinations of the six TFs selected.
4– cells 10 days after SOX10 induction. Expression levels normalized
s. *p < 0.05.
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Figure 3. Phenotypic Characterization of SOX10-Induced OLs by Immunocytochemistry
(A) Untransduced NPCs express the early OPC marker OLIG2 but not O4.
(B) Quantification of OPC/OL marker expression in the whole culture after 10 days of SOX10 induction.
(legend continued on next page)
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all MBP+ cells were Ki67 (Figure 3L), and hence post-
mitotic, consistent with the acquisition of a mature OL
phenotype.
SOX10-Induced Cells Resemble Primary OLs at the
Transcriptome Level
To assess if SOX10-induced OLs resembled primary OLs, we
performed RNA-sequencing (RNA-seq) on purified O4+
cells derived from four different hPSC lines: the hESC H9
and the hiPSC ChiPSC6b, Sigma-iPSC0028, and BJ1
(healthy donor-derived) lines. The transcriptome of the
O4+ cells was combined with published transcriptome
data from different brain cells (GalC+ OLs, CD90+ neurons,
CD45+ myeloid cells, HepaCAM+ astrocytes, BSL-1+ endo-
thelial cells, and the whole cortex) (Zhang et al., 2016;
Abiraman et al., 2015).
Principal-component analysis and unsupervised hierar-
chical clustering on the entire transcriptome identified a
very distinct cluster encompassing different brain-
derived OL samples, as well as the SOX10-induced O4+
cells, separated from neurons, astrocytes and other non-
ectodermal-derived cells (Figures 4A and 4B). To further
characterize the maturity of the generated O4+ OLs, we
also included samples consisting of immature, intermedi-
ate, and mature OLs isolated from human fetal tissues
(Abiraman et al., 2015). Comparison of OL-specific
markers (Cahoy et al., 2008; Nielsen et al., 2006) revealed
that O4+ cells derived from H9 and Sigma-iPSC0028 lines
co-clustered with intermediate OLs, while ChiPSC6b and
BJ1 O4+ cells clustered more closely to immature OLs
(Figure 4C).
Next, we compared SOX10-PSC O4+ cells (average values
of all PSC-derived cells) with different primary OLs using a
sequence alignment map (Figures 4D and 4E). We identi-
fied 916 (13.48%) differentially expressed genes between
matureOLs and PSC-O4+ cells (fold change >2 and false dis-
covery rate < 0.05) (699 up- and 217 downregulated genes
in PSC-O4+ cells) and 240 (3.53%) differentially expressed
genes between intermediate OLs and PSC-O4+ cells (all up-
regulated in PSC-O4+ cells) (Table S1), confirming that O4+
cells were highly similar to mature/intermediate primary
OLs (Figure 4E). Over 85% (47/53) of OL-specific genes
(includingMAG, MOG, SOX10, and OLIG2) were expressed
at comparable levels in O4+ cells and primary OLs
(Figure 4D).(C–H) Representative images of the cultures showing expression of th
small proportion.
(J) Expression of the proteolipid protein (PLP) in O4+ cells isolated o
(K) The expression of SOX10 was found in all MBP+ OLs (exemplified
(L) None of the MBP+ OLs expressed the Ki67 marker (exemplified wit
Representative images of N = 3–5 independent differentiations. Hoe
20 mm for (J).Lastly, we performed gene ontology (GO) analysis to
identify classes of genes that were similarly expressed be-
tween O4+ hPSC-derived cells and primary OLs. When
compared with primary intermediate OLs, a higher num-
ber of shared GO pathways were obtained, including those
referred to CNS development as well as to OL development
(Table S2). In addition, other termswere related to cytoskel-
eton organization and protein modifications, pathways
associated to OLs (Nielsen et al., 2006). Overall, these
results support the notion that SOX10-induced O4+ cells
are highly comparable at the transcriptome level with
primary OLs, especially intermediate OLs.
Inducible Single-Copy SOX10 Overexpression from
the AAVS1 Locus Efficiently Induced OL Cell
Conversion
To avoid effects of random integration of the SOX10 trans-
gene resulting from lentiviral transduction, and also to
avoid the use of this technology for OL generation, we
created an hESC line wherein SOX10 was introduced in
the safe harbor locus AAVS1, using recombinase-mediated
cassette exchange in hPSC lines containing an FRT-flanked
cassette, which contained a hygromycin-resistance/thymi-
dine kinase selection cassette (Ordova´s et al., 2015). This
created 100% homogeneous hESCs containing either an
SOX10 or an SOX10-eGFP cassette under a doxycycline-
inducible promoter (Figures S4A and S4B).
Addition of doxycycline to hESCs induced the expres-
sion of SOX10 or SOX10-eGFP in >99% of cells (Figures
S4C and S4D). Induction of SOX10 on day 0, without
prior neural commitment, did not result in the genera-
tion of MBP+ OLs (not shown). When hPSCs were first
fated to NPCs for 8 days, followed by addition of doxycy-
cline and culture in OL differentiation medium, already
50% O4+ cells were found on day 4, and 89.3% ± 0.6%
by day 7, which was sustained at later time points
(Figure S4E). The emergence of O4+ cells was accompa-
nied by progressively increased levels of OPC/OL
markers, in both SOX10 and SOX10-eGFP transgenic lines
(Figure S4F). Immunostaining further demonstrated the
OL identity of the cells: MBP+ cells could be detected by
day 7, and its expression increased progressively by day
10 of induction (day 18 of the overall differentiation cul-
ture; Figure S4G). No contamination with neurons was
observed.e OL markers O4, MBP, and MOG. (I) TUJI+ neurons are present in a
n day 10 following SOX10 induction.
with white arrows).
h white arrows), and hence present a postmitotic phenotype.
chst 33258 (blue) was used as nuclear marker. Scale bars: 50 mm;
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Figure 4. Global Transcriptome Comparison of SOX10-Induced Cells with Primary Different Brain Lineages
(A) Hierarchical clustering of whole-genome expression profile of SOX10-induced O4+ cells (black), different primary OL samples (green),
myeloid cells (orange), neurons (yellow), endothelial cells from cortex (red), astrocytes (light blue), and whole cortex (pink).
(B) Principal-component analysis (PCA) of different samples mentioned in (A).
(C) Hierarchical clustering and heatmap comparison of OL-specific markers among PSC-derived O4+ cells and primary OLs.
(legend continued on next page)
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SOX10-Induced OLs Myelinate Both Shiverer Mouse
and hPSC-Derived Cortical Neurons
To demonstrate that SOX10-induced O4+ cells have func-
tional characteristics of OLs, we tested if they were capable
of myelinating neuronal axons. To address myelination in
an in vivo context, purified O4+ cells were injected in brain
slices from homozygous shiverer (shi/shi) mice (MBP defi-
cient) and slices were analyzed 10 days later. Immunostain-
ing demonstrated efficient engraftment and homogeneous
spreading of the transplanted humanhNA+ cells within the
tissue, with 48.13% ± 4.15% of cells also expressing MBP
(Figures 5A–5C). Moreover, MBP+ OL projections wrapping
NF200+ neuronal axons could be observed 10 days after in-
jection (Figures 5D and 5E).
We also assessed ifmyelination occurred in in vitro co-cul-
tures. We generated cortical neurons from human iPSCs as
described previously (Shi et al., 2012). Neuronal progeni-
tors were replated and allowed to mature for 10–14 days.
O4+ cells, isolated and purified on day 10 following
SOX10 induction, were co-cultured with cortical neuronal
progeny for an additional 20 days in OL myelination me-
dium. Regions wherein TUJI+ axons were aligned with
MBP+ OLs could already be seen a few days later (not
shown). By day 20 of co-culture, O4+ cells extended MBP+
regions aligned with axons at multiple locations (Figures
5F–5K). Transverse sections of reconstructed confocal mi-
croscopy images demonstrated the presence of MBP+ ex-
tensions fully wrapping neuronal axons (Figures 5H and
5I). 3D reconstructions also demonstrated the presence of
MBP+ sheaths surrounding TUJ1+ axonal prolongations
(Figures 5J and 5K). At the ultrastructural level, cytoplasmic
regions of OLs were frequently observed surrounding
neuronal axons (Figures 5L and 5M) and were able to
formmultilayer compact myelin sheaths (Figure 5Q). Early
myelination of neuronal axons was also observed (Figures
5O and 5P). These results indicate that SOX10-induced
OLs matured into myelinating OLs that ensheathed
and wrapped axons in both an in vivo context, as well as
when co-cultured with hPSC-derived neurons in vitro.
Efficient Generation of OLs from iPSCs Derived from
Patients with MS and ALS
To determine the robustness of the protocol, and to
demonstrate that OLs can also be generated from iPSCs of
patients with neurodegenerative diseases wherein OLs
have been shown to play a causal role, we compared the
generation of OLs from hPSCs from healthy donors(D) Pairwise scatterplot of log10 gene expression of PSC-derived O4
+ c
OLs. Gray, genes expressed at similar levels (<2-fold difference), with
genes that are >2-fold higher or >2-fold less expressed in PSC-derive
(E) Venn diagram depicting the number of genes expressed in comm
primary intermediate and mature OLs.(hESC-H9 and hiPSC ChiPSC6b, Sigma-iPSC0028, and
BJ1 lines), with iPSC lines from two primary progressive
MS (PPMS) patients and from two patients with a familial
form of ALS (fALS) caused by mutations in the genes super-
oxide dismutase (SOD1A4V) or C9ORF72.
We found no substantial differences in the expression of
intermediate and late OL marker transcripts among the
eight cell lines analyzed at different time points (Figure 6A).
In addition, no significant differences in the efficiency
of generating O4+ cells were seen among the lines
(50%–65% O4+ cells; Figure 6B). Finally, approximately
10% of MBP+ cells were present on day 22 in the SOX10-
induced NPC progeny from all lines examined, with the
exception of BJ1-derived cells, which contained only
6.34% ± 0.70% MBP+ cells (Figure 6C). In addition, MBP+
progeny from PSCs of healthy donors and from PPMS
and fALS patients had similar morphology (Figure 6D).
Thus, the SOX10-mediated differentiation protocol
could generate intermediate and mature OLs with similar
efficiencies also from PPMS and fALS iPSC lines only after
22 days of differentiation. This proves the robustness of
the protocol irrespective of the iPSC lines used to generate
O4+/MBP+ OLs.
Creation of a Myelinating Co-culture System for High-
Throughput Drug Screening
Currently, no good assays are available to identify and vali-
date drugs that can enhance myelination. The existing
platforms are based mostly on primary murine OLs
cultured in the absence (Mei et al., 2014; Lee et al.,
2012a) or presence of neurons (Deshmukh et al., 2013; Lar-
iosa-Willingham et al., 2016). Recently, in vitromyelination
systems based on murine PSCs suitable for high-
throughput screening (HTS) have been developed (Najm
et al., 2015; Kerman et al., 2015). However, such a model
using hPSC-derived neuronal and OL progeny has not yet
been described.
To enableHTS approaches, we adapted andoptimized the
cortical neuron-OL co-culture system to 96- and 384-well
plate format. Following induction of SOX10 for 10 days,
purified O4+ cells could be cryopreserved, with >90%
cells remaining viable and functional after thawing
(not shown). To test if hPSC-derived neuron-OL co-
cultures allow identification of myelination-enhancing
factors (e.g., triiodothyronine, T3) or differentmedications,
SOX10-induced purified O4+ cells were cultured on top of
maturing neurons for 20 days, and expression of MBPells (N = 12) versus intermediate (N = 6) and mature (N = 3) primary
blue arrows identifying key OL-specific genes; red and green dots,
d O4+ cells compared with primary intermediate and mature OLs.
on or differently (>2-fold change) in SOX10-induced O4+ cells and
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evaluated. Co-cultures were supplemented or not with two
drugs identified in a murine stem cell-derived HTS to
enhance MBP+ expression, miconazole and clobetasol
(Najm et al., 2015). In addition, we tested the effect of the
g-secretase and Notch signaling inhibitor DAPT, reported
to have a positive influence on in vitromyelination of mu-
rine OPCs (Lariosa-Willingham et al., 2016), and pranlu-
kast, a blocker of the olig2-targeted G-protein-coupled re-
ceptor Gpr17, reported to enhance remyelination and OL
survival, but not yet tested in in vitro screens (Ou et al.,
2016). The readout included assessment of the total MBP+
area, number of MBP+ cells, and MBP+ intensity (Figure 7).
MBP expression increased 1.5- to 2-fold when T3 was
added compared with control (DMSO) conditions (Marta
et al., 1998). Miconazole induced a similar increase, and
addition of pranlukast induced a 1.5- to 2.5-fold increase
in MBP expression. The highest levels of MBP expression
were observed for clobetasol, reaching a 3- to 4-fold in-
crease of MBP expression compared with control, which
was significantly higher than the effect of T3 when
matched-pair analysis was performed (Figure S5). By
contrast, DAPT did not enhance MBP expression. Similar
results were obtained in both 96- and 384-well assay for-
mats (Figure 7A), with little variation between intra- or in-
ter-plate replicates, and for all threeMBP-staining readouts.
Thus, the fully human neuron-OL co-culture system
described here can be successfully scaled across multiple
formats, allowing HTS to identify and validate compounds
involved in myelination. This system could be used as well
to study the mechanisms underlying OL-mediated
neuronal dysfunction or death.DISCUSSION
Our understanding of the complex OL biology and mech-
anisms underlying several OL diseases has been limitedFigure 5. SOX10-Induced OLs Myelinate Both Shiverer Mouse Bra
(A–E) Confocal microscopy images of O4+ purified SOX10-induced cel
(A) Whole-slice image showing homogeneous dispersion of the injecte
slices showing grafting and maturation of the injected cells. (D an
ensheathing NF200+ neuronal axons.
(F–Q) Confocal and transmission electron microscopy (TEM) images o
O4+ cells. (F) Overview of the co-culture. (G) Amplification of a repr
neuronal axons. (H and I) Magnifications of an OL showing, at differe
reconstruction suggesting the wrapping of axons by an OL. (K) Detaile
an axon (red) by MBP+ prolongations (green). Nuclei counterstained
(red) surrounded by an OL (green). (M) Myelin-like structures are fou
structure where compact myelin formation can be observed. (O) TEM e
(arrow). (P) Detailed micrograph of an OL prolongation (#) starting
(Q) Magnification showing the formation of a multilayer compact my
Scale bars: 1 mm (A), 50 mm (B and C), 20 and 2 mm inserts (D and E
200 nm (Q).by the difficulties of obtaining human OLs. Since the
implementation of hESCs/hiPSC technology, different
methods have been described whereby OLs can be gener-
ated from hPSCs (Nistor et al., 2005; Hu et al., 2009;
Wang et al., 2013; Douvaras et al., 2014), but inefficiently
and, therefore, impeding the use of these cells for disease
modeling or drug development.
To overcome these issues, we hypothesized that overex-
pression of TFs known to play a role in OL specification
and/or maturation would enhance the efficiency as well
as the speed with which OL could be generated from
hPSCs. We selected 16 TFs known to regulate human
and/or murine OL specification and/or maturation (Cahoy
et al., 2008; Pozniak et al., 2010; Weng et al., 2012; Najm
et al., 2013; Yang et al., 2013) and tested if their overexpres-
sion would enhance OPC/OL fating. By a combination of
methods, we demonstrated that overexpression of SOX10
alone in NPCs induced 60% of cells expressing O4, of
which 20% also co-expressed the myelin protein MBP.
The SOX genes are TFswith a characteristic high-mobility
group domain, involved in developmental specification
and classified into nine groups based on sequence similar-
ity and function (Wegner, 2010). Among them, the SOXE
group of TFs, composed of SOX8, SOX9 and SOX10, is
involved in specification of myelinating glial cells, both
SCs and OLs (Weider and Wegner, 2017). We obtained
late OPC specification when either SOX8, SOX9 or SOX10
were overexpressed, consistent with the previously
described role of these TFs during OL specification.
Although redundant functions have been described for
these three TFs due to the high sequence preservation of
the functional domains, Sox10 is considered as the main
Sox TF regulating OL specification and maturation, with
also epigenetic functions (Weider et al., 2013; Vogl et al.,
2013). As SOX10 is known to be involved in SC develop-
ment (Weider et al., 2013), we also assessed if SCs were
concomitantly induced in our cultures. However, we couldin Slices and hPSC-Derived Cortical Neurons
ls injected into Shi/ mouse brain slices 10 days after injection.
d cells (human nuclear antigen, hNA+). (B and C) Overview images of
d E) Detailed images showing MBP+ prolongations annealing and
f the co-culture between hPSC-derived neurons and SOX10-induced
esentative region with mature OLs extending their processes over
nt locations, the complete ensheathment of neuronal axons. (J) 3D
d 3D reconstruction of a region showing complete ensheathment of
with Hoechst 33258 (blue). (L) TEM image showing neuronal axons
nd in regions with axon tracts. (N) Magnification of a myelinating
xample where myelination of a neuronal axon is partially complete
to form a layered myelin sheet around a neuronal structure (*).
elin structure.
), 2 mm (L), 0.5 mm (M), 100 nm (N), 200 nm (O), 200 nm (P), and
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not detect cells with typical SC markers. Thus, although
SOX10 plays a role in maturation and myelin production
of both cell types, the lack of SC induction in our assay is
likely due to the fact that the NPC and subsequent differen-
tiation conditions are OL specific and not supportive for SC
development, in line with their differential developmental
origin compared with OLs (Zawadzka et al., 2010).
The basic helix-loop-helix protein OL lineage transcrip-
tion factor 2 (Olig2) is considered to be themain TF respon-
sible for OPC specification. Most OPCs generated from
NPCs in the motor neuron progenitor region of the spinal
cord express Olig2, and Olig2 is believed to orchestrate OL
differentiation by inducing the expression of Nkx2.2 and
later that of Sox10 (Sim et al., 2011). To mimic conditions
present in the motor neuron progenitor region during
NPC induction from PSCs, we combined dual SMAD
inhibition with the caudalizing and ventralizing
factors, RA and SHH agonist, respectively. This resulted
in 51.7% ± 4.6% of NPCs that expressed OLIG2 and
81.76% ± 2.67% the ventral marker HOXB4 (Franklin
et al., 2012; Lee et al., 2012b). Overexpression of SOX10
alone in these NPCs resulted in the specification andmatu-
ration of OLs. However, overexpression of SOX10 in un-
committed hPSCs did not result in OPCs and differentia-
tion (not shown), demonstrating that SOX10 alone
cannot directly induce an OL fate in hPSCs, but only in
already neural-committed precursors. Of note, we did not
detect neural/glial antigen 2 (NG2)- or platelet-derived
growth factor receptor a (PDGFRa)-positive cells following
SOX10 overexpression, suggesting that SOX10 causes the
direct generation of late OPCs/OLs from OLIG2+ NPCs
without an intermediate OPC stage.
Recently, Ehrlich et al. (2017) published a protocol for OL
generation from hPSCs also based on TF overexpression.
They demonstrated that SOX10 was the only TF capable
of inducing O4 expression, which was further enhanced
when combined with OLIG2 and NKX6.2. They observed
a similar frequency of O4+ cells and final maturation to
MBP+ OLs at the end of differentiation as we describe
here. However, the Ehrlich et al. protocol required
28 days to generate 70% O4+ cells, and an additional
7 days for efficient MBP+ OL production after NPCFigure 6. Generation of OLs from Different Lines Including MS an
(A) Heatmaps of qRT-PCR analysis performed at different stages of OPC
eight different hPSCs used: four lines derived from healthy donors (h
gressive MS patients (PPMS-102 and -104), and two from patients with
(fALS-C9orf72) (SOX10e = endogenous SOX10).
(B) O4 expression by FACS of the eight hPSC lines analyzed after 10 d
(C) Quantification of the total percentage of MBP+ cells.
(D) Representative images of MBP+ OLs obtained after 10 days from t
Hoechst 33258 (blue) was used as nuclear marker. Scale bars: 50 mm
Data represented as mean ± SEM of N = 3 independent experiments ptransduction. By contrast, our protocol requires 10 days
following NPC transduction with SOX10 to generate
similar levels of O4+ cells of which 20% also express MBP.
Although the reasons for the different requirement of
three versus one TF to generate O4+ cells from NPC are
not clear, we hypothesize that these differences might be
due to differences in the initial NPC generation. Ehrlich
et al. induced neural specification via embryoid bodies in
the presence of SMAD inhibitors and the Wnt activator
and caudalizing molecule CHIR99021, combined with
the ventralizing SHH agonist Purmorphamine. By contrast,
we induced NPCs by dual SMAD inhibition in adherent
cultures, and in the presence of low concentrations of RA,
essential for efficient generation of OLIG2+ precursors and
subsequent OPC specification (Douvaras et al., 2014). The
fact that we only need the single TF SOX10 may allow
future studies to developmethods that will directly or indi-
rectly target endogenous SOX10 to generate OLs that could
be used clinically.
To further characterize the OL progeny, we performed
RNA-seq analysis on day 22 O4+-purified OLs, and
compared their transcriptome with previously described
datasets from primary neural populations including imma-
ture to mature OLs (Zhang et al., 2014, 2016; Abiraman
et al., 2015). This demonstrated that SOX10-induced O4+-
purified cells clustered with bona fide OLs and differed
from other brain cells. We found slight discrepancies in
the levels of OL maturity among the four lines tested,
which may be the consequence of variability between cells
from which O4+ cells were derived, as these cells have
different developmental origins, are derived from geneti-
cally distinct individuals and/or hiPSCs may differ in their
level of epigenetic reprogramming (Bilic and Izpisua Bel-
monte, 2012). In addition, we included in the analysis
the OLs described by Ehrlich et al. (2017) (Figure S3),
finding that all OLs clustered together and the OLs gener-
ated by both studies presented highly shared transcrip-
tomes with primary OLs, indicating that TF-induced OLs
resemble primary OLs at the transcriptome level.
The robustness of the protocol was further validated by
deriving OLs from two MS and two fALS patients. These
MS/fALS patient-derived OLs expressed similar markersd fALS Patients
/OL differentiation induced by SOX10 overexpression comparing the
ESC-H9, hiPSCs ChiPSC6b, Sigma, and BJ1), two from primary pro-
familial ALS with mutations in SOD1 (fALS-SOD1 A4V) and C9orf72
ays in OL differentiation medium.
he eight hPSC lines.
.
er line.
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and morphology compared with healthy donor-derived
cells. Among the eight lines tested, the only significant dif-
ference we found was a reduction in the proportion of
MBP+ cells in SOX10-induced cells from the BJ1 line
(Figure 6C). Notably, we also found a reduction in the per-
centage of the OLIG2+ population (51.7% versus 30.7%)
after 12 days of neural induction in BJ1 cells. As hiPSCs
may have skewed capacities to the differentiation toward
different lineages (Bilic and Izpisua Belmonte, 2012), we
hypothesize that decreased neural differentiation capacity
of the BJ1 iPSCs may determine the lower frequency of
mature OLs obtained at the end of the SOX10-induced
protocol.
To evaluate the myelination capacity of SOX10-induced
O4+ OLs, we first injected the cells into MBP/– homozy-
gous shiverer mouse brain slices and demonstrated not
only efficient engraftment and dispersion within the slice,
but also wrapping of neuronal axons by MBP+ OL prolon-
gations in this in vivo context 10 days after injection. To
further demonstrate the myelinating capabilities of gener-
ated O4+ cells in vitro, we established a fully hPSC-derived
co-culture system, demonstrating that induced OLs were
able to produce MBP+ extensions aligning with neuronal
axons and myelin ensheathment by about 20 days
following co-culture, even though SOX10 was no longer
overexpressed during the last 10 days of the co-culture, sug-
gesting that SOX10 overexpression was no longer required
at this stage to support OL maturation and myelination.
Myelin formation surrounding axons and the presence of
compact multi-layered myelin was also observed in the
co-culture system at the ultrastructural level, fully demon-
strating the myelination capacity of SOX10-derived OLs.
To enable HTS for drugs that improve myelination, we
successfully adapted the co-culture system to 96- and
384-well plate formats. This allowed us to demonstrate
that MBP expression increased considerably when T3, a
known inducer of myelin production (Marta et al., 1998),
was added to the medium. Clobetasol, previously shown
to enhance myelination both in vitro and in vivo (Najm
et al., 2015), increased MBP expression to even higherFigure 7. All hPSC-Derived OL-Neuron Co-culture Can Address My
(A) Relative MBP expression to control cultures (0.1% DMSO and no T
(60 ng/mL), DAPT (1 mM), miconazole (1 mM), clobetasol propionate (5
MBP+ area, number of MBP+ cells and total MBP+ intensity. Shown are
combination of the two.
(B) Gaussian dot plots of the average values of all single wells in the six
where N = 90) for the three variables based on MBP expression.
(C) Representative images of the co-cultures assessing the effects of t
identified for the analysis.
Hoechst 33258 (blue) was used as nuclear marker. Scale bars: 100 m
condition of N = 7–8 independent experiments for 96-well plates, N =
plates. *p < 0.05, **p < 0.01.levels than T3.MBP expression was also induced bymicon-
azole, but to a lesser extent. Increase in MBP staining was
also seen after treatment with pranlukast, a compound
known to inhibit signaling via the Gpr17 receptor, and re-
ported to enhance remyelination andOL survival inmouse
(Ou et al., 2016). As this occurred already at the mM level,
pranlukast might be an interesting drug candidate to be
tested for (re)myelination in pathological conditions
(Mogha et al., 2016). However, DAPT did not significantly
increase MBP staining, in contrast with previous studies
(Lariosa-Willingham et al., 2016). Differences in myelin
production might be due to the fact that we tested the ef-
fect of the different compounds in OL-neuron co-cultures,
while previous studies assessed myelination of OLs in the
absence of neurons (Mei et al., 2014; Lee et al., 2012a;
Kerman et al., 2015; Ou et al., 2016; Mogha et al., 2016).
This all-human neuron-OLs co-culture system allows to
evaluate the effect of drugs on myelin expression, which
should also allowmodeling of pathways involved in neural
diseases whereinOLs are involved, either because of defects
in myelination or defects in neuronal support.
Finally, we demonstrated that induction of SOX10
expression in NPCs following a single copy insertion of
SOX10 in a safe harbor locus of hPSCs (Ordova´s et al.,
2015) is sufficient to induce O4+ and MBP+ OL progeny.
A similarmethodology has recently been described by Paw-
lowski et al. (2017), who demonstrated that overexpression
of SOX10 and OLIG2 induced cells with phenotypic fea-
tures of OLs in a similar time frame as we demonstrate
here, even though no functional characterization of the
cells was performed. Generation of stable inducible
SOX10-hPSC lines would be an invaluable tool for drug
screens, as they do not suffer from random integrations
and the incomplete efficiency of viral vectors, allowing a
very efficient and robust generation of OLs.
In summary, we demonstrated that overerexpression of
only SOX10 in hPSC-derived NPCs allows a very efficient
and rapid generation of OLs from hPSCs, which can myeli-
nate nude axons both in in vivo and in vitro contexts. The
protocol is robust, as it induces with similar efficiencyelinating Drugs in an HTS Setting
3) of the different compounds and drugs affecting myelination: T3
mM) and pranlukast (22.8 mM). Three variables were assessed: total
results for co-cultures in 96-well plates, in 384-well plates, or the
culture conditions (N = 160 for all conditions except for pranlukast,
he different tested conditions on myelination and of the MBP+ mask
m. Data are represented as average values per plate ± SEM of each
6–7 for 384-well plates, and N = 12–15 for both 96- and 384-well
Stem Cell Reports j Vol. 10 j 655–672 j February 13, 2018 669
and speed O4+ cells from hESCs and hiPSCs of healthy do-
nors, as well as from hiPSCs from patients with MS or fALS.
A platform was also developed wherein myelination of
neurons can be evaluated in an HTS format to demonstrate
the effect of myelinating factors and molecules. This all-
hPSC-derived neuron-OL myelinating co-culture platform
has the potential to significantly improve testing and vali-
dation of candidate pro-myelinating drugs for congenital
or acquired demyelinating diseases, and allow assessment
of mechanisms underlying neurodegenerative diseases
wherein decreased OL-mediated neuronal support is
fundamental to disease onset or progression.EXPERIMENTAL PROCEDURES
Generation of NPCs and OLs from hPSCs
hPSCs were dissociated to single cells on day 2. On day 0, me-
dium was switched to N2B27 medium supplemented with
SB431542 10 mM, LDN193189 1 mM, and 100 nM RA until day 8,
when SB431542 and LDN193189 were withdrawn and 1 mM
Smoothened agonist added. On day 12, cells were dissociated,
plated, and transduced with viral vectors. Next day, medium
was changed to OL differentiation medium with the addition of
1 mg/mL doxycycline. Cells were maintained for 7–10 days.
Co-culture with Neurons and Adaptation for HTS
Cortical neurons were generated fromWT hPSCs as described pre-
viously (Shi et al., 2012). Neuronal progenitors (50 days) were re-
plated and allowed to mature for 10–14 days. Afterward, purified
O4+ cells were seeded above the maturing neurons and cultures
were maintained for 20 days in co-culture medium in the absence
of T3 and AA, with the addition of doxycycline and the presence of
the candidate compounds.
Animal procedures (assessment of OLmyelination in brain slices
derived from shiverer mice) were approved by a Dutch Ethical
Committee for animal experiments.
Detailed experimental procedures can be found in the Supple-
mental Information.
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